title: Interleukin-2 in clinical trials: other factors to be considered.
authors.forename: E C
authors.initials: EC
authors.lastname: Nannini
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D019380:Anti-HIV Agents; D007376:Interleukin-2